Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Cancer Immunology, Immunotherapy : CII
|
May 6, 2004
A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer
Steve Nicholson, C C Bomphray, H Thomas, et al.
The Journal of Investigative Dermatology
|
January 11, 2013
Plasma microRNA-21 is associated with tumor burden in cutaneous melanoma
Gerald Saldanha, Linda Potter, Priya Shendge, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2010
A phase 2 study of vatalanib in metastatic melanoma patients
Natalie Cook, Bristi Basu, Swethajit Biswas, et al.
The Lancet. Oncology
|
September 11, 2012
Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial
Tim Eisen, Heikki Joensuu, Paul D Nathan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2025
Standardization of radiation therapy to Inguinal and Pelvic Lymph Nodes in Locally Advanced Cancer of the Penis, as Defined by the International Penile Advanced Cancer Trial (InPACT)
Sian Cooper, Steve Nicholson, Juanita Crook, et al.
British Journal of Cancer
|
October 21, 2021
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis
Steve Nicholson, Holly Tovey, Tony Elliott, et al.
The Lancet. Oncology
|
April 22, 2014
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study
Pippa G Corrie, Andrea Marshall, Janet A Dunn, et al.
Cell Reports. Medicine
|
February 28, 2024
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial
James Larkin, Richard Marais, Nuria Porta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2014
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative
Jan Bogaerts, Matthew R Sydes, Nicola Keat, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Cancer Immunology, Immunotherapy : CII
|
May 6, 2004
A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer
Steve Nicholson, C C Bomphray, H Thomas, et al.
The Journal of Investigative Dermatology
|
January 11, 2013
Plasma microRNA-21 is associated with tumor burden in cutaneous melanoma
Gerald Saldanha, Linda Potter, Priya Shendge, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2010
A phase 2 study of vatalanib in metastatic melanoma patients
Natalie Cook, Bristi Basu, Swethajit Biswas, et al.
The Lancet. Oncology
|
September 11, 2012
Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial
Tim Eisen, Heikki Joensuu, Paul D Nathan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2025
Standardization of radiation therapy to Inguinal and Pelvic Lymph Nodes in Locally Advanced Cancer of the Penis, as Defined by the International Penile Advanced Cancer Trial (InPACT)
Sian Cooper, Steve Nicholson, Juanita Crook, et al.
British Journal of Cancer
|
October 21, 2021
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis
Steve Nicholson, Holly Tovey, Tony Elliott, et al.
The Lancet. Oncology
|
April 22, 2014
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study
Pippa G Corrie, Andrea Marshall, Janet A Dunn, et al.
Cell Reports. Medicine
|
February 28, 2024
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial
James Larkin, Richard Marais, Nuria Porta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2014
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative
Jan Bogaerts, Matthew R Sydes, Nicola Keat, et al.
Page
of 2